20/20 GeneSystems, Inc. operates as a specialized clinical diagnostic company, focusing primarily on screening for cancer and analyzing viral infections. The firm offers advanced blood tests for the early detection of various cancers, including a notable product called OneTest. Additionally, it provides services for identifying viruses, such as rapid COVID-19 test kits like the Assure COVID-19 IgG/IgM rapid assay. The company also manages the Clinical Lab Innovation Axcelerator (CLIAx), a collaborative laboratory space designed to help developers of diagnostic products bring their innovations to the U.S. market. Furthermore, 20/20 GeneSystems delivers its cancer screening algorithm technology to healthcare providers via a software-as-a-service (SaaS) platform. It actively supports emerging diagnostic startups by offering them access to shared lab infrastructure and vital resources. Founded in 2000, the company is headquartered in Gaithersburg, Maryland.
